Search

Displaying results 4271 - 4280 of 5924 in total
  1. Drug

    Recombinant stabilized RSV A prefusion F antigen

    go.drugbank.com/drugs/DB18713
    ApprovedInvestigational

    [L49555] Abrysvo was approved for the same indications in the EU in August 2023[L49565] and Canada in December 2023.

  2. Drug

    Bromopride

    go.drugbank.com/drugs/DB09018
    Investigational

    Bromopride is a dopamine antagonist used as an antiemetic. Its prokinetic properties are similar to those of metoclopramide. It is unavailable in America or the United Kingdom.

    Categories: Dopamine D2 Receptor Antagonists
  3. Drug

    Anthramycin

    go.drugbank.com/drugs/DB19555
    Experimental

    Anthramycin has a monoisotopic molecular weight of 315.12 Da.

  4. Drug

    Maytansine

    go.drugbank.com/drugs/DB19582
    Investigational

    Maytansine has a monoisotopic molecular weight of 691.29 Da.

  5. Drug

    Nitraquazone

    go.drugbank.com/drugs/DB19659
    Experimental

    Nitraquazone has a monoisotopic molecular weight of 311.09 Da.

  6. Drug

    Isoxepac

    go.drugbank.com/drugs/DB19733
    Experimental

    Isoxepac has a monoisotopic molecular weight of 268.07 Da.

  7. Drug

    Apalcillin

    go.drugbank.com/drugs/DB19777
    Experimental

    Apalcillin has a monoisotopic molecular weight of 521.14 Da.

  8. Drug

    Citenazone

    go.drugbank.com/drugs/DB19786
    Experimental

    Citenazone has a monoisotopic molecular weight of 210.0 Da.

  9. Drug

    Lexofenac

    go.drugbank.com/drugs/DB19789
    Experimental

    Lexofenac has a monoisotopic molecular weight of 230.09 Da.

  10. Drug

    Rutamycin

    go.drugbank.com/drugs/DB19908
    Experimental

    Rutamycin has a monoisotopic molecular weight of 776.51 Da.

    Synonyms: Oligomycin d